Cargando…
Efficacy and Cardiotoxicity of Liposomal Doxorubicin-Based Chemotherapy in Advanced Breast Cancer: A Meta-Analysis of Ten Randomized Controlled Trials
BACKGROUND: Various trials have compared the efficacy and toxicity of liposomal doxorubicin-based chemotherapy with the conventional formulation of doxorubicin although arriving at inconsistent conclusions. To derive a conclusive assessment of the efficacy and cardiotoxicity associated with chemothe...
Autores principales: | Xing, Meiyuan, Yan, Feifei, Yu, Sufen, Shen, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512701/ https://www.ncbi.nlm.nih.gov/pubmed/26204517 http://dx.doi.org/10.1371/journal.pone.0133569 |
Ejemplares similares
-
Pegylated and liposomal doxorubicin is associated with high mortality and causes limited cardiotoxicity in mice
por: Stark, Christoffer, et al.
Publicado: (2018) -
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
por: Khattry, Navin, et al.
Publicado: (2009) -
Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies
por: Dorostkar, Hamidreza, et al.
Publicado: (2023) -
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
por: Basal, Omnia A., et al.
Publicado: (2023) -
Development of a multivariable clinical prediction model for liposomal doxorubicin-induced cardiotoxicity in adult breast cancer patients: a retrospective multicenter study
por: Sun, Yiqi, et al.
Publicado: (2022)